Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J MacDonald

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|April 25, 2003
Re "Solutions must be the answer"William J MacDonald
JTCVS Structural and Endovascular|June 17, 2026
How to manage residual aortic regurgitation after an aortic valve-sparing operation: Practical tipsGift Owolabi, Megan M Chung, Jack Nickles, et al.
American Journal of Cancer Research|August 10, 2023
Broad spectrum integrin inhibitor GLPG-0187 bypasses immune evasion in colorectal cancer by TGF-β signaling mediated downregulation of PD-L1William J MacDonald, Brooke Verschleiser, Lindsey Carlsen, et al.
American Journal of Translational Research|January 17, 2025
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell linesConnor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell LinesConnor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Cancers|February 13, 2025
Heterogeneity in CancerWilliam J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research|January 12, 2026
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinomaWilliam J MacDonald, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Oncotarget|March 13, 2025
Signaling pathway dysregulation in breast cancerDinara Ryspayeva, Attila A Seyhan, William J MacDonald, et al.
European Journal of Medicinal Chemistry|December 30, 2014
Design, synthesis and bioevaluation of novel 6-(4-Hydroxypiperidino)naphthalen-2-ol-based potential Selective Estrogen Receptor Modulators for breast cancerAmitabh Jha, Yogesh Yadav, Ajay B Naidu, et al.
Cancer Letters|May 23, 2026
Biomarker-Guided Strategies for Tumor Vasculature: From Imaging Advances to Novel Therapeutic InterventionsConnor Purcell, Dinara Ryspayeva, Jay Gopal, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|April 25, 2003
Re "Solutions must be the answer"William J MacDonald
JTCVS Structural and Endovascular|June 17, 2026
How to manage residual aortic regurgitation after an aortic valve-sparing operation: Practical tipsGift Owolabi, Megan M Chung, Jack Nickles, et al.
American Journal of Cancer Research|August 10, 2023
Broad spectrum integrin inhibitor GLPG-0187 bypasses immune evasion in colorectal cancer by TGF-β signaling mediated downregulation of PD-L1William J MacDonald, Brooke Verschleiser, Lindsey Carlsen, et al.
American Journal of Translational Research|January 17, 2025
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell linesConnor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell LinesConnor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Cancers|February 13, 2025
Heterogeneity in CancerWilliam J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research|January 12, 2026
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinomaWilliam J MacDonald, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Oncotarget|March 13, 2025
Signaling pathway dysregulation in breast cancerDinara Ryspayeva, Attila A Seyhan, William J MacDonald, et al.
European Journal of Medicinal Chemistry|December 30, 2014
Design, synthesis and bioevaluation of novel 6-(4-Hydroxypiperidino)naphthalen-2-ol-based potential Selective Estrogen Receptor Modulators for breast cancerAmitabh Jha, Yogesh Yadav, Ajay B Naidu, et al.
Cancer Letters|May 23, 2026
Biomarker-Guided Strategies for Tumor Vasculature: From Imaging Advances to Novel Therapeutic InterventionsConnor Purcell, Dinara Ryspayeva, Jay Gopal, et al.
Pageof 2